HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome. University of Thi-Qar Journal of Science, [S. l.], v. 5, n. 3, p. 48–56, 2015. DOI: 10.32792/utq/utjsci/v5i3.138. Disponível em: https://jsci.utq.edu.iq/index.php/main/article/view/138.. Acesso em: 21 nov. 2024.